Product Reports Resources Pricing Login Book a demo

Docquity

Health Tech & Medtech · Singapore, Singapore · Founded 2015

Docquity is a Southeast Asian startup that operates as a digital platform for healthcare professionals. It provides a trusted community where doctors can exchange ideas, access educational resources, and participate in virtual discussions with world-class speakers. The platform serves healthcare professionals, primarily doctors, across the region, positioning itself in the digital healthcare market. The business model of Docquity is centered around providing a space for continuous learning and collaboration among healthcare professionals. Users can take courses, earn certificates, attend webinars, and browse an extensive virtual library. The platform also offers a database of recorded sessions, journals, publications, and more, which users can access at their own convenience. This feature allows busy doctors to stay informed about hot topics in their fields and the world of healthcare in general. In addition, Docquity facilitates case collaboration by allowing users to ask their peers for answers on open cases or share information about successful cases. This feature aims to enhance the value of the community by promoting knowledge sharing and peer learning. The company generates revenue through subscription fees. By being part of the Docquity community, users can save on these costs, indicating that the platform likely operates on a freemium model where basic access is free, but premium features require payment. Keywords: Digital Healthcare, Continuous Learning, Collaboration, Doctors Community, Webinars, Virtual Library, Case Collaboration, Subscription Model, Southeast Asia, Medical Insights.

Valuation $100–500M
Revenue $10–50M
Headcount 100–500
Total funding $50–100M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Docquity and the history behind them.

Investors

9 investors on Docquity's cap table

Sourced from Dealroom's funding history.

Series A 4 investors entered at this stage
Genesia Ventures
ITOCHU
Singapore Press Holdings
SPH Ventures
Series B+ 5 investors entered at this stage
Global Brain Corporation
iGlobe Partners
Alkemi Growth Capital
Infocom
KDV Capital

Global footprint

Where Docquity has talent and traffic

Workforce by country
12 countries with
team presence
🇮🇳 India34%
🇮🇩 Indonesia21.9%
🇵🇭 Philippines12.2%
🇲🇾 Malaysia12.2%
🇻🇳 Vietnam8.3%
Top 5 of 12 shown
Web traffic by country
54K monthly visits
across markets
🇮🇩 Indonesia34.4%
🇮🇳 India14.6%
🇺🇸 United States10.2%
🇲🇾 Malaysia9.8%
🇵🇭 Philippines6.7%
Top 5 markets shown

Talent graph

The shape of Docquity's talent

Dealroom maps Docquity's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

12 team members profilednamed & role-tagged by Dealroom
355 employeestotal headcount
5 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Docquity's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Docquity

An AI-synthesized read of the highest-engagement posts about Docquity on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Docquity on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.